Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)

Study ID: NCT06789757
Start Date: 2025-02-25
End Date: 2027-01-27
Study Type

Interventional

Study Phase

Phase2

No. of Participants

19

Intervention / Treatment

Memantine Hydrochloride

Infinite

Atezolizumab

Sponsor

Inova Health Care Services

Source: clinicaltrials.gov

Share:
Add to list

Phase 1, Open-label, Dose-escalation Trial with CD38-SADA:177 Lu-DOTA Drug Complex in Subjects with Relapsed or Refractory Non-Hodgkin Lymphoma

Study ID: NCT05994157
Start Date: 2025-02
End Date: 2028-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

CD38-SADA:177Lu-DOTA Complex

Sponsor

Y-mAbs Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Prostate Active Surveillance Study

Study ID: NCT00756665
Start Date: 2008-07
End Date: 2032-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3000

Intervention / Treatment
Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

An Optimal Dose Finding Study of N-Acetylcysteine in Patients with Myeloproliferative Neoplasms

Study ID: NCT05123365
Start Date: 2022-01-03
End Date: 2026-11-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

N-Acetylcysteine

Sponsor

University of California, Irvine

Source: clinicaltrials.gov

Share:
Add to list

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Study ID: NCT05800665
Start Date: 2023-05-02
End Date: 2026-07-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

160

Intervention / Treatment

Rouqtalt 4

Sponsor

Genentech, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Integrative Approaches for Cancer Survivorship (IACS3)

Study ID: NCT06633926
Start Date: 2025-03-31
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

104

Intervention / Treatment

Nutrition Education

Lifestyle Counseling

Yoga

Marma therapy

Educational Intervention

Quality of Life Questionnaire Administration

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis

Study ID: NCT04878003
Start Date: 2021-04-13
End Date: 2025-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

52

Intervention / Treatment

KRT-232

TL-895

Sponsor

Kartos Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Study ID: NCT06227026
Start Date: 2024-02-20
End Date: 2027-01-15
Study Type

Interventional

Study Phase

Phase1

No. of Participants

6

Intervention / Treatment

Anti-CD19 CAR-T cells

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

Female Asian Nonsmoker Screening Study

Study ID: NCT05164757
Start Date: 2021-03-01
End Date: 2033-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

NYU Langone Health

Source: clinicaltrials.gov

Share:
Add to list

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Study ID: NCT06562543
Start Date: 2025-01-14
End Date: 2027-10-04
Study Type

Interventional

Study Phase

Phase4

No. of Participants

78

Intervention / Treatment

Fruquintinib

Sponsor

Takeda

Source: clinicaltrials.gov

Share:
Add to list